Table 2.
Randomized trials of preoperative radiotherapy (RT) and surgery versus surgery alone.
Study, year [Reference] | Participants | Number of patients | Interventions | Median Survival (Months) | Survival Rate (%) | Adverse Effects (Number of Patients) | ||||
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | ||||||
Launois et al. 1981 [21] | 124 patients March 1973-June 1976 France, single centre, squamous cell | 67 | 64 – 90 Gy preop RT + esophagectomy | 4.5 | 46 | 20 | 15 | 14 | 10 | perioperative mortality was 23% in both groups. |
versus | versus | versus | versus | |||||||
57 | esophagectomy (left thoracotomy) | 8.2 (mean) | 50 | 35 | 25 | 20 | 12 | |||
p = NS, but NR | ||||||||||
Gignoux et al. 1987 [22] | 229 patients [dates not reported] EORTC, 8 centres, squamous cell, no cervical lesions, no previous cancer, no previous treatment. | 115 | 33 Gy preop RT + esophagectomy | 12.3 | 55 | 24 | 20 | 17 | 10 | tracheosophageal fistula, 2; bleeding, 1; esophagitis, 1; respiratory deaths, 6 |
versus | versus | versus | versus | versus | ||||||
114 | esophagectomy | 12 (mean) | 57 | 30 | 14 | 11 | 9 | respiratory deaths, 8 | ||
No difference in survival (p = 0.94), but RT may delay local recurrence | ||||||||||
Wang et al. 1989 [23] | 206 patients June 1977-May 1985 China, single centre histology not reported < 65 years age, < 8 cm length no metastases | 104 | 40 Gy preop RT + esophagectomy | NR | - | - | - | - | 35 | leaks, 1; perioperative deaths, 5 |
versus | versus | versus | versus | versus | ||||||
102 | esophagectomy | NR | - | - | - | - | 30 | leaks, 5; perioperative deaths, 5 | ||
No difference in survival (p > 0.05). | ||||||||||
Nygaard* 1992 [24] | 108 patients Jan 1983-Jan 1988 Scandinavia, multi centre squamous cell < 75 years of age, Karnofsky score > 50, T1, T2, Nx, M0 > 21 cm from incisors | 58 | 35 Gy preop RT + esophagectomy | 10 | 44 | 25 | 21 | - | - | respiratory, 5; leaks, 2; postoperative deaths, 4 |
versus | versus | versus | versus | versus | ||||||
50 | esophagectomy | 7 | 34 | 13 | 9 | - | - | respiratory, 5; leaks, 2; postoperative deaths, 5 | ||
No difference in survival (p = 0.08). | ||||||||||
Arnott 1992 [25] | 176 patients 1979–1983 Scotland, single centre < 80 years, squamous cell adenocarcinoma, distal 2/3 esophagus | 90 | 20 Gy preop RT + esophagectomy | 8 | 40 | 22 | 13 | 9 | 9 | respiratory, 10; postoperative deaths, 10 |
versus | versus | versus | versus | versus | ||||||
86 | esophagectomy (left thoracoabdominal) | 8 | 40 | 28 | 23 | 21 | 17 | respiratory, 5; postoperative deaths, 8; surgical, 2 | ||
No difference in survival (p = 0.40). | ||||||||||
Fok* 1994 [5] | 79 patients 1968–1981 Hong Kong, single centre Squamous cell, middle 1/3 esophagus | 40 | 24–53 Gy preop RT + esophagectomy | 11 | 42 | 34 | 24 | 10 | 10 | respiratory, 20; postoperative deaths, 12; leaks 11 |
versus | versus | versus | versus | versus | ||||||
39 | esophagectomy (right thoracotomy, left neck, and abdomen) | 22 | 58 | 36 | 24 | 16 | 16 | respiratory, 15; postoperative deaths, 3; leaks, 7 | ||
No difference in survival. |
*Patients randomized to four groups; data shown are for radiotherapy + surgery versus surgery alone.
Note: EORTC, European Organization for Research and Treatment of Cancer.